1. Do Drug Metabolism and Pharmacokinetic Departments Make Any Contribution to Drug Discovery?

   • Dennis Smith
   • Esther Schmid
   • Barry Jones

   Current Opinion 13 September 2012 Pages: 1005 - 1019

   

2. Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT₄ Receptor Partial Agonist with Promotile Activity

   • Silke Appel-Dingemanse

   Review Articles 13 September 2012 Pages: 1021 - 1042

   

3. Clinical Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mixtures

   • Paris Roach
   • James R. Woodworth

   Review Articles 13 September 2012 Pages: 1043 - 1057

   

4. Pharmacokinetics and Pharmacodynamics of Rapacuronium Bromide

   • William J. Wight
   • Peter M. C. Wright

   Review Articles 13 September 2012 Pages: 1059 - 1076

   

5. Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part II

   • Jane Alcorn
   • Patrick J. McNamara

   Review Articles 13 September 2012 Pages: 1077 - 1094

   

6. Bayesian Estimation of Methotrexate Pharmacokinetic Parameters and Area Under the Curve in Children and Young Adults with Localised Osteosarcoma

   • Annick Rousseau
   • Christophe Sabot
   • Pierre Marquet

   Original Research Article 13 September 2012 Pages: 1095 - 1104

   

7. Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women

   • Jianfeng Lu
   • Marc Pfister
   • Lewis Sheiner

   Original Research Article 13 September 2012 Pages: 1105 - 1113